Brian Cheng

Sep 03, 2026

On Sep 03, 2026, ZYME was given a Overweight rating by Brian Cheng, with a target price of 33. Despite the Buy call, shares fell from 26.435 to 26.435, challenging the optimistic stance.

Aug 04, 2026

IMVT received a Overweight rating from Brian Cheng on Aug 04, 2026, aiming for 50. Price action was muted, as shares hovered around 38.1 despite the bullish outlook.

Jul 24, 2026

On Jul 24, 2026, Brian Cheng published a Overweight outlook on STTK, with a target of 10. Market action contradicted the Buy thesis, as shares slipped to 6.15.

Jul 17, 2026

Brian Cheng on Jul 17, 2026 assigned ARWR a Overweight rating, with a price target of 95. The Buy call aligned well with market performance, producing a gain of 11.39%.

Jul 15, 2026

On Jul 15, 2026, Brian Cheng reaffirmed TNGX with a Overweight rating, targeting 46. Shares slid 22.74% despite the recommendation, highlighting downside risks.

Jun 02, 2026

ODTX was rated Overweight by Brian Cheng on Jun 02, 2026, with a price objective of 26. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

May 14, 2026

On May 14, 2026, Brian Cheng initiated coverage on TARA with a Overweight rating and target of 26. The Buy call has yet to be validated as shares remain 22.21 away from the target.

May 13, 2026

Brian Cheng issued a Overweight recommendation for KYTX on May 13, 2026, price target set at 29. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

May 11, 2026

On May 11, 2026, GLUE was evaluated by Brian Cheng, who gave a Overweight rating and target of 31. Investors saw limited payoff as shares fell short of the 31 target.

May 11, 2026

Brian Cheng rated CGON as Overweight on May 11, 2026, setting a price target of 96. Shares have remained stable near 72, leaving the 96 target still in play.

Mar 19, 2026

On Mar 19, 2026, PTGX was given a Overweight rating by Brian Cheng, with a target price of 106. The stock rallied 42.76% after the rating, narrowing the gap to the target of 106 and validating the bullish stance.

Mar 02, 2026

EIKN received a Overweight rating from Brian Cheng on Mar 02, 2026, aiming for 29. The rating hasn’t played out as hoped, with the stock trading 38.10% below expectations.

Feb 02, 2026

On Feb 02, 2026, Brian Cheng published a Overweight outlook on RVMD, with a target of 122. Shares gained 109.29%, underscoring the accuracy of the bullish outlook toward 122.

Feb 02, 2026

Brian Cheng on Feb 02, 2026 assigned TGTX a Overweight rating, with a price target of 46. The Buy call aligned well with market performance, producing a gain of 89.82%.

Dec 10, 2025

On Dec 10, 2025, Brian Cheng reaffirmed KYMR with a Overweight rating, targeting 125. The recommendation was supported by strong follow-through as the stock rose from 117 to 117.

Oct 02, 2025

Brian Cheng rated ABSI as Overweight on Oct 02, 2025, setting a price target of null. The call has proven timely, with shares rising 132.11% toward the price target of null.

Sep 18, 2025

On Sep 18, 2025, CRSP was given a Overweight rating by Brian Cheng, with a target price of 70. Despite the Buy call, shares fell from 52.26 to 52.26, challenging the optimistic stance.

Sep 18, 2025

ROIV received a Overweight rating from Brian Cheng on Sep 18, 2025, aiming for 20. Momentum has favored the Buy call, with shares climbing from 40.94 to 40.94, rewarding those who trusted the recommendation.

Aug 07, 2025

Brian Cheng on Aug 07, 2025 assigned IMNM a Overweight rating, with a price target of 22. The Buy call aligned well with market performance, producing a gain of 152.99%.

Mar 27, 2025

On Mar 27, 2025, Brian Cheng initiated coverage on AAPG with a Overweight rating and target of null. The Buy call has yet to be validated as shares remain -16.67 away from the target.